DK0675878T3 - Nye D-vitaminanaloger - Google Patents

Nye D-vitaminanaloger

Info

Publication number
DK0675878T3
DK0675878T3 DK94903741.0T DK94903741T DK0675878T3 DK 0675878 T3 DK0675878 T3 DK 0675878T3 DK 94903741 T DK94903741 T DK 94903741T DK 0675878 T3 DK0675878 T3 DK 0675878T3
Authority
DK
Denmark
Prior art keywords
pct
compounds
thiol
sec
date
Prior art date
Application number
DK94903741.0T
Other languages
Danish (da)
English (en)
Inventor
Gunnar Grue-Soerensen
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of DK0675878T3 publication Critical patent/DK0675878T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94903741.0T 1992-12-23 1993-12-17 Nye D-vitaminanaloger DK0675878T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226877A GB9226877D0 (en) 1992-12-23 1992-12-23 Chemical compounds

Publications (1)

Publication Number Publication Date
DK0675878T3 true DK0675878T3 (da) 1997-04-28

Family

ID=10727157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94903741.0T DK0675878T3 (da) 1992-12-23 1993-12-17 Nye D-vitaminanaloger

Country Status (15)

Country Link
US (1) US5554599A (el)
EP (1) EP0675878B1 (el)
KR (1) KR100295977B1 (el)
AT (1) ATE148454T1 (el)
AU (1) AU668638B2 (el)
CA (1) CA2146775C (el)
DE (1) DE69307929T2 (el)
DK (1) DK0675878T3 (el)
ES (1) ES2098123T3 (el)
FI (1) FI108225B (el)
GB (1) GB9226877D0 (el)
GR (1) GR3022774T3 (el)
NZ (1) NZ259317A (el)
RU (1) RU2136660C1 (el)
WO (1) WO1994014766A1 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
ATE195513T1 (de) * 1994-04-11 2000-09-15 Chugai Pharmaceutical Co Ltd 22-thiavitamin-d3-derivate
DE69634494T2 (de) 1995-12-28 2006-02-23 Chugai Seiyaku K.K. Verwendung von Vitamin-D-Derivaten zur Herstellung eines Medikaments zur Behandlung von malignen Tumormetastasen
US6869940B2 (en) 1995-12-28 2005-03-22 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) * 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
IL130484A (en) * 1996-12-20 2004-07-25 Chugai Pharmaceutical Co Ltd History of -16N-Vitamin-D
US6184398B1 (en) 1996-12-20 2001-02-06 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin D derivatives
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
ES2274785T3 (es) 1999-04-01 2007-06-01 Johns Hopkins University Analogos de 1-alfa,25-dihidroxi vitamina d3 no calcemicos, antiproliferativos, transcripcionalmente activos que contienen azufre.
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
NZ517978A (en) 1999-09-29 2003-11-28 Colotech As Composition comprising ASA, calcium and 1,25 DHC for the prevention of colorectal cancer
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7074777B2 (en) 2000-04-19 2006-07-11 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivatives
CA2411409C (en) 2000-06-15 2011-05-17 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivatives
EP1419143B1 (en) * 2001-08-22 2009-04-15 Johns Hopkins University 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3
ATE425178T1 (de) * 2001-10-19 2009-03-15 Isotechnika Inc Synthese von cyclosporinanalogen
EP1511725B1 (en) 2002-06-13 2012-02-01 Johns Hopkins University 24-sulfoximine vitamin d3 compounds
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
CN107019795A (zh) 2009-01-27 2017-08-08 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3化合物
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
NZ714801A (en) 2013-05-29 2021-07-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
ATE195513T1 (de) * 1994-04-11 2000-09-15 Chugai Pharmaceutical Co Ltd 22-thiavitamin-d3-derivate

Also Published As

Publication number Publication date
EP0675878A1 (en) 1995-10-11
CA2146775A1 (en) 1994-07-07
RU95113480A (ru) 1997-03-20
AU5808794A (en) 1994-07-19
WO1994014766A1 (en) 1994-07-07
CA2146775C (en) 2005-06-28
EP0675878B1 (en) 1997-01-29
KR950703501A (ko) 1995-09-20
ATE148454T1 (de) 1997-02-15
DE69307929T2 (de) 1997-09-04
GB9226877D0 (en) 1993-02-17
FI108225B (fi) 2001-12-14
US5554599A (en) 1996-09-10
FI952972A0 (fi) 1995-06-16
KR100295977B1 (ko) 2001-11-14
DE69307929D1 (de) 1997-03-13
GR3022774T3 (en) 1997-06-30
ES2098123T3 (es) 1997-04-16
NZ259317A (en) 1997-05-26
RU2136660C1 (ru) 1999-09-10
AU668638B2 (en) 1996-05-09
FI952972A (fi) 1995-06-16

Similar Documents

Publication Publication Date Title
DK0675878T3 (da) Nye D-vitaminanaloger
Bahrami et al. Direct conversion of thiols and disulfides into sulfonamides
LV10456A (lv) Triazolpiridazina atvasinajumi to iegusanas panemiens un pielietojums
ES8506566A1 (es) Procedimiento para la produccion de derivados de 1-carbonil-1-fenil-2-azolil-etanol
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
SU633479A3 (ru) Способ получени стильбеновых соединений
ES2107682T3 (es) Analogos noveles de la vitamina d.
UA75598C2 (uk) Спосіб одержання анілінових сполук, проміжна сполука та її застосування
FI86057B (fi) 2-bensyltio- eller 2-bensylsulfoxid-1- cyklopenten-1-karboxamider, foerfaranden foer deras framstaellning och deras anvaendning vid syntes av 4,5-trimetylen-4-isotiazolin-3-oner.
US2467895A (en) Piperazine derivatives and method of preparing the same
IE903448A1 (en) Benzanilides
JPS6050186B2 (ja) ２−メルカプトエチルアミンハロゲン化水素酸塩類の製造法
CA1118445A (en) N,n'-[bis(n-cyanoguanyl)] crystamine derivatives
Mizuno et al. Reaction of thiolates with carbon monoxide
NZ241117A (en) Sulphonylaminoalkylphenylalkylamine derivatives; preparatory processes and pharmaceutical compositions
US3308132A (en) 6, 8-dithiooctanoyl amides and intermediates
ES263931A1 (es) Procedimiento de obtenciën de derivados de tiaxanteno
US3631071A (en) S-aroyl- s-thioaroyl- and s-((n-aryl) hydrocarbylimidoyl)hydrosulfamines
AU6520698A (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
US7033564B2 (en) Lithium aluminum hydride-based selenating reagent and preparation methods using same
US5017725A (en) Preparation of addition salts of cysteamine with acids
KR20100043220A (ko) 설파닐 유도체 및 합성 중간체로서의 이들의 용도
HUP0003059A2 (hu) Eljárás 2-alkiltiobenzoesav-származékok előállítására
SU698511A3 (ru) Гербицидна композици
SU1216183A1 (ru) Способ получени ,цис,цис-3-тиа-1,4-пентадиен-1,5-дикарбоновой кислоты или ее динатриевой соли